Small molecule therapy for managing moderate to severe psoriatic arthritis-Reference-Cited by-同舟云学术

Small molecule therapy for managing moderate to severe psoriatic arthritis

Published:2017-09-18 Issue:15 Volume:18 Page:1557-1567
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Costa Luisa¹,Del Puente Antonio¹,Peluso Rosario¹,Tasso Marco¹,Caso Paolo²,Chimenti Maria Sole³,Sabbatino Vincenzo¹,Girolimetto Nicolò¹,Benigno Carolina¹,Bertolini Nicoletta¹,Del Puente Aurora⁴,Perricone Roberto³,Scarpa Raffaele¹,Caso Francesco¹^ORCID

Affiliation:

1. Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy

2. Geriatric Unit, Faculty of Medicine and Psychology, “Sapienza” University of Rome, S. Andrea, Hospital, Rome, Italy

3. Rheumatology, allergology and clinical immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy

4. Department of Medicine and Surgery, University of Milan “Bicocca”, Naples, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1378343

Reference144 articles.

1. Simple clinical indicators for early psoriatic arthritis detection

2. Psoriatic arthritis and psoriasis: differential diagnosis

3. The Definition and Measurement of Axial Psoriatic Arthritis

4. New Developments in Magnetic Resonance Imaging of the Nail Unit

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis;Expert Opinion on Biological Therapy;2024-07-26

2. Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study;Arthritis Research & Therapy;2023-10-11

3. JAK Inhibitors in Psoriatic Disease;Clinical, Cosmetic and Investigational Dermatology;2023-10

4. How do we treat psoriatic arthritis in the era of GRAPPA recommendations: predictive factors for bDMARDs usage in PsA patients in a real life setting;2023-09-29

5. Oral small‐molecule Janus kinase inhibitors and phosphodiesterase 4 inhibitors for psoriatic arthritis: a Bayesian network meta‐analysis;International Journal of Dermatology;2023-07-10